Cargando...
The benefit of everolimus in recurrent/epithelioid angiosarcoma patients: Case reports and literature review
Epithelioid angiosarcoma (EA) is a kind of rare malignant soft tissue sarcoma, with high recurrence/metastatic rate and poor prognosis. To date, no effective standardized treatment regimen has been available for patients with recurrence/metastatic EA. Everolimus is an oral rapamycin derivative that...
Guardado en:
| Publicado en: | Oncotarget |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5706933/ https://ncbi.nlm.nih.gov/pubmed/29212287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21832 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|